Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
10 Fundamental Tips and Deceives to Lift Your Cell phone's Exhibition - 2US FDA grants market authorization to six on! PLUS nicotine pouch products
- 3Instructions to Safeguard Your Speculations In the midst of Changing Disc Rates
- 410 High priority Contraptions for Tech Aficionados
- 5ADHD drugs work, but not the way experts thought
- A definitive Manual for Internet Mastering and Expertise Improvement
- US FDA declines to approve Corcept's drug for rare hormonal disorder
- Understanding Various Sorts of Financial balances: An Extensive Outline
- NASA Artemis II tracker: Where is the Orion now and when will it reach the moon?
- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- Why boosting production of Venezuela's 'very dense, very sloppy' oil could harm the environment
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Investigate Something else for Less: Financial plan Travel Objections
